Literature DB >> 25016062

Functional characterisation of different MLL fusion proteins by using inducible Sleeping Beauty vectors.

K Wächter1, E Kowarz1, R Marschalek2.   

Abstract

Our focus is the identification, characterisation and functional analysis of different MLL fusions. In general, MLL fusion proteins are encoded by large cDNA cassettes that are difficult to transduce into haematopoietic stem cells. This is due to the size limitations of the packaging process of those vector-encoded RNAs into retro- or lentiviral particles. Here, we present our efforts in establishing a universal vector system to analyse different MLL fusions. The universal cloning system was embedded into the backbone of the Sleeping Beauty transposable element. This transposon has no size limitation and displays no integration preference, thereby avoiding the integration into active genes or their promoter regions. We utilised this novel system to test different MLL fusion alleles (MLL-NEBL, NEBL-MLL, MLL-LASP1, LASP1-MLL, MLL-MAML2, MAML2-MLL, MLL-SMAP1 and SMAP1-MLL) in appropriate cell lines. Stable cell lines were analysed for their growth behaviour, focus formation and colony formation capacity and ectopic Hoxa gene transcription. Our results show that only 1/4 tested direct MLL fusions, but 3/4 tested reciprocal MLL fusions exhibit oncogenic functions. From these pilot experiments, we conclude that a systematic analysis of more MLL fusions will result in a more differentiated picture about the oncogenic capacity of distinct MLL fusions.
Copyright © 2014 The Authors. Published by Elsevier Ireland Ltd.. All rights reserved.

Entities:  

Keywords:  LASP1; MAML2; MLL fusion proteins; NEBL; SMAP1

Mesh:

Substances:

Year:  2014        PMID: 25016062     DOI: 10.1016/j.canlet.2014.06.016

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  14 in total

1.  The role of the Janus-faced transcription factor PAX5-JAK2 in acute lymphoblastic leukemia.

Authors:  Dagmar Schinnerl; Klaus Fortschegger; Maximilian Kauer; João R M Marchante; Reinhard Kofler; Monique L Den Boer; Sabine Strehl
Journal:  Blood       Date:  2014-12-16       Impact factor: 22.113

2.  Pan-Cancer Landscape Analysis Reveals Recurrent KMT2A-MAML2 Gene Fusion in Aggressive Histologic Subtypes of Thymoma.

Authors:  Lucas R Massoth; Yin P Hung; Dora Dias-Santagata; Maristela Onozato; Nikunj Shah; Eric Severson; Daniel Duncan; Brendan J Gillespie; Nathan F Williams; Jeffrey S Ross; Jo-Anne Vergilio; Shannon K Harkins; Krzysztof Glomski; Valentina Nardi; Lawrence R Zukerberg; Robert P Hasserjian; Abner Louissaint; Erik A Williams
Journal:  JCO Precis Oncol       Date:  2020-02-26

3.  Unraveling the Activation Mechanism of Taspase1 which Controls the Oncogenic AF4-MLL Fusion Protein.

Authors:  Samaneh Sabiani; Tim Geppert; Christian Engelbrecht; Eric Kowarz; Gisbert Schneider; Rolf Marschalek
Journal:  EBioMedicine       Date:  2015-04-16       Impact factor: 8.143

Review 4.  An update on the LIM and SH3 domain protein 1 (LASP1): a versatile structural, signaling, and biomarker protein.

Authors:  Martin F Orth; Alex Cazes; Elke Butt; Thomas G P Grunewald
Journal:  Oncotarget       Date:  2015-01-01

5.  Transposon-mediated generation of BCR-ABL1-expressing transgenic cell lines for unbiased sensitivity testing of tyrosine kinase inhibitors.

Authors:  Konstantin Byrgazov; Chantal Blanche Lucini; Bettina Berkowitsch; Margit Koenig; Oskar A Haas; Gregor Hoermann; Peter Valent; Thomas Lion
Journal:  Oncotarget       Date:  2016-11-22

6.  High-performance gene expression and knockout tools using sleeping beauty transposon system.

Authors:  Kaishun Hu; Yu Li; Wenjing Wu; Hengxing Chen; Zhen Chen; Yin Zhang; Yabin Guo; Yin Dong
Journal:  Mob DNA       Date:  2018-11-26

7.  A vector platform for the rapid and efficient engineering of stable complex transgenes.

Authors:  Carsten Jäckel; Melanie Schmitt Nogueira; Nadja Ehni; Christiane Kraus; Julius Ranke; Maike Dohmann; Elfriede Noessner; Peter J Nelson
Journal:  Sci Rep       Date:  2016-10-03       Impact factor: 4.379

Review 8.  Systematic Classification of Mixed-Lineage Leukemia Fusion Partners Predicts Additional Cancer Pathways.

Authors:  Rolf Marschalek
Journal:  Ann Lab Med       Date:  2016-03       Impact factor: 3.464

9.  NDEL1-PDGFRB fusion gene in a myeloid malignancy with eosinophilia associated with resistance to tyrosine kinase inhibitors.

Authors:  K Byrgazov; R Kastner; M Gorna; G Hoermann; M Koenig; C B Lucini; R Ulreich; M Benesch; V Strenger; H Lackner; W Schwinger; P Sovinz; O A Haas; M van den Heuvel-Eibrink; C M Niemeyer; O Hantschel; P Valent; G Superti-Furga; C Urban; M N Dworzak; T Lion
Journal:  Leukemia       Date:  2015-08-30       Impact factor: 11.528

10.  Identification and Characterization of Non-Coding RNAs in Thymoma.

Authors:  Guanglei Ji; Rongrong Ren; Xichao Fang
Journal:  Med Sci Monit       Date:  2021-07-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.